MGNK — Mologen AG Balance Sheet
0.000.00%
Last trade - 00:00HealthcareHighly SpeculativeMicro Cap
- €0.06m
- -€2.76m
- €3.05m
Annual balance sheet for Mologen AG, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.
2014 December 31st | 2015 December 31st | 2016 December 31st | 2017 December 31st | 2018 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 13.6 | 24.6 | 20.5 | 6.52 | 8.02 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 1.02 | 1.36 | 0.767 | 1.52 | 0.617 |
| Total Inventory | |||||
| Total Current Assets | 14.6 | 26 | 21.3 | 8.06 | 9.34 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 0.234 | 0.239 | 0.025 | 0.027 | 0.016 |
| Net Intangible Assets | |||||
| Other Long Term Assets | |||||
| Total Assets | 15.1 | 26.4 | 21.4 | 8.11 | 9.36 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 1.75 | 6.89 | 7.4 | 7.5 | 4.75 |
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 1.75 | 6.89 | 9.53 | 13 | 10.3 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Total Equity | 13.3 | 19.5 | 11.8 | -4.87 | -0.945 |
| Total Liabilities & Shareholders' Equity | 15.1 | 26.4 | 21.4 | 8.11 | 9.36 |
| Total Common Shares Outstanding |